From the UCL Centre for Cardiovascular Genetics, and UCL Institute for Human Health and Performance, University College London, London, UK.
Transfusion. 2011 Nov;51(11):2286-94. doi: 10.1111/j.1537-2995.2011.03170.x. Epub 2011 May 12.
The association of red blood cell (RBC) storage on morbidity outcome after cardiac surgery is debated. We sought to clarify the association of the age of transfused blood on outcome in patients undergoing cardiac surgery.
Data were drawn from a prospective, observational cohort study of morbidity outcome in patients undergoing cardiac surgery. Blood transfusion data were obtained retrospectively via the Trust blood bank electronic records. Old blood was defined as more than 14 days old. The primary outcome measure was postoperative length of stay (PLOS). Secondary outcome measures included renal failure and morbidity as defined within the postoperative morbidity survey.
A total of 176 (39.6%) of 444 participants received a blood transfusion. Patients transfused with new blood had a reduced PLOS compared with patients receiving exclusively old or any old blood (old blood ± new blood; 7 days vs. 8 days, p = 0.04 and vs. 10 days, p = 0.002, respectively). In patients who only had 1 unit transfused, PLOS was longer in those receiving only old blood compared with those receiving only new blood (8 days vs. 6 days, p = 0.02) with a 3.8-fold risk of longer stay. Compared with patients receiving exclusively new blood, patients receiving any old blood had a higher incidence of new renal complications (65.7% vs. 43.9%, p = 0.008). Each 1-day increase in storage was associated with a 7% increase in risk of new renal complications.
Our data support previous suggestions of an association between transfusion of older RBCs and poorer outcome in cardiac surgery patients. Randomized controlled trials are required to determine the true causal nature of any such association.
关于红细胞(RBC)储存与心脏手术后发病率之间的关系存在争议。我们试图阐明输注血液的年龄与心脏手术患者结局之间的关系。
数据来自前瞻性、观察性心脏手术后发病率队列研究。通过信托血库电子记录回顾性获得输血数据。旧血定义为超过 14 天的血液。主要结局测量指标是术后住院时间(PLOS)。次要结局指标包括肾功能衰竭和术后发病率调查中定义的发病率。
在 444 名参与者中,共有 176 名(39.6%)接受了输血。与接受纯旧血或任何旧血的患者相比,输注新血的患者 PLOS 更短(旧血±新血;7 天 vs. 8 天,p = 0.04 和 10 天,p = 0.002)。在仅输注 1 单位的患者中,与仅输注新血的患者相比,仅输注旧血的患者 PLOS 更长(8 天 vs. 6 天,p = 0.02),住院时间延长的风险增加 3.8 倍。与接受纯新血的患者相比,接受任何旧血的患者新发肾脏并发症的发生率更高(65.7% vs. 43.9%,p = 0.008)。每储存 1 天,新发肾脏并发症的风险增加 7%。
我们的数据支持之前关于输注较陈旧 RBC 与心脏手术患者较差结局之间存在关联的建议。需要进行随机对照试验来确定任何此类关联的真正因果性质。